fda glp-1 news november 2025 Shortage = Over Lilly, chasing Novo, expects second-quarter

Insurance does not currently cover our program, but weve kept pricing low to make care accessible

[If youre worried about potential harms,] you should discuss them with your physician.

Neurath MF

In doing so, the FDA risks setting a precedent that, like Makena, could undermine its broader public health obligations

Your vial will typically include: A colored cap over a rubber stopper A label showing the drug name, concentration, and active ingredient A beyond-use date and storage instructions The pharmacys contact information Youll use the same vial for multiple doses, drawing up your prescribed amount with a new syringe each week